APA (7th ed.) Citation

Hagel, S., Bach, F., Brenner, T., Bracht, H., Brinkmann, A., Annecke, T., . . . Pletz, M. W. (2022). Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: A randomized controlled trial. Intensive care medicine, 48(3), 311-321. https://doi.org/10.1007/s00134-021-06609-6

Chicago Style (17th ed.) Citation

Hagel, Stefan, et al. "Effect of Therapeutic Drug Monitoring-based Dose Optimization of Piperacillin/tazobactam on Sepsis-related Organ Dysfunction in Patients with Sepsis: A Randomized Controlled Trial." Intensive Care Medicine 48, no. 3 (2022): 311-321. https://doi.org/10.1007/s00134-021-06609-6.

MLA (9th ed.) Citation

Hagel, Stefan, et al. "Effect of Therapeutic Drug Monitoring-based Dose Optimization of Piperacillin/tazobactam on Sepsis-related Organ Dysfunction in Patients with Sepsis: A Randomized Controlled Trial." Intensive Care Medicine, vol. 48, no. 3, 2022, pp. 311-321, https://doi.org/10.1007/s00134-021-06609-6.